Customer support

xie@china-sinoway.com
English
banner
Products
Home

API

Ropivacaine Hydrochloride 132112-35-7

Ropivacaine Hydrochloride 132112-35-7

98% up by HPLC
  • Product Details

Product Information


Product name

Ropivacaine Hydrochloride / Ropivacaine HCL

CAS No.

132112-35-7

Molecular Formula

C17H26N2O·HCl·

Molecular Weight

328.88

Quality Standard

98% up by HPLC

Appearance

White powder


COA of Ropivacaine Hydrochloride


  Items

Specifications

Results

Appearance

White Powder

Complies

Assay (HPLC)

98%min

99.8%

Odor

Characteristic

Complies

Sieve analysis

100% pass 80 mesh

Complies

Heavy Metal

<10ppm

Complies

As

< 0.1ppm

0.05ppm

Pb

< 0.1ppm

0.05ppm

Cd

< 0.1ppm

0.05ppm

Residual solvents

<100ppm

Complies

Residual pesticide

Negative

Complies

Total Plate Count

< 1000 cfu/g

Complies

Yeast&Mold

< 100 cfu/g

Complies

E.Coli

 Negative

Complies

 Salmonella

 Negative

Complies

Conclusion

Meet the specification of standards


Usage


Function of Ropivacaine Hydrochloride


Since it was discovered that long-acting local anesthetics can induce cardiac arrest, people have been seeking alternative medicines that are less fat-soluble and safer. Ropivacaine is such a new type of long-acting amide local anesthetic, which has a long duration of action, and has anesthetic and analgesic effects. Its pharmacological characteristics are low cardiotoxicity, obvious separation of sensory block and motor block, and peripheral vasoconstriction. Therefore, the drug is especially suitable for postoperative analgesia and obstetric anesthesia.

Compared with traditional local anesthetics, Ropivacaine HCL has the following advantages:

1. Curative effect: The action time of ropivacaine is significantly longer than other long-acting local anesthetics, and the action time of subcutaneous infiltration anesthesia is 2 to 3 times longer than that of bupivacaine of the same concentration.

2. Unique curative effect-the sensory-motor block separation of ropivacaine is much greater than that of bupivacaine, and the clearance rate is higher, making it more suitable for analgesia.

3. Strong controllability-the anesthetic effect of ropivacaine is dose-dependent, which means that the degree of sensory and motor block produced by ropivacaine is predictable and controllable.

4. Low toxic and side effects-Ropivacaine does not have the disadvantage of greater cardiotoxicity of general long-acting local anesthetics. Cardiotoxicity is rarely caused by this product, and the fetus has good tolerance to this product.

Send A Message

If you are interested in our products and want to know more details,please leave a message here,we will reply you as soon as we can.
Related Products

Mupirocin powder
MUPIROCIN 12650-69-0
99% up / GMP
IMATINIB MESYLATE
IMATINIB MESYLATE 220127-57-1
In-house Standard
CEFTIOFUR SODIUM
CEFTIOFUR SODIUM 104010-37-9
In-house Specification
OSELTAMIVIR PHOSPHATE
OSELTAMIVIR PHOSPHATE 204255-11-8
99% up , Pharmaceutical Grade
THYMOPENTIN
THYMOPENTIN 69558-55-0
99% up Medical Grade
LOSARTAN POTASSIUM
LOSARTAN POTASSIUM 124750-99-8
98.5% up, USP32 
AZILSARTAN
AZILSARTAN 147403-03-0
99% up, JP/ GMP / PMDA / DMF
Send A Message
Send A Message
If you are interested in our products and want to know more details,please leave a message here,we will reply you as soon as we can.

Home

Products

about

Contact